Саркомы мягких тканей и костей, ассоциированные с беременностью

Авторы:

Виталий Андреевич Державин,

Артем Викторович Бухаров

Журнал: Онкология. Журнал им. П.А. Герцена. 2026;15(2):82-86.

DOI: 10.17116/onkolog20261502182

Прочитано: 236 раз

Резюме

Диагноз онкологического заболевания у беременной женщины рассматривается как крайне драматическая ситуация, при которой возникает конфликт рисков для здоровья и жизни матери и плода. В такой ситуации необходимо взвешенно относиться к лечению и сопоставлять потенциальные угрозы для плода от хирургического вмешательства, системных методов лечения и лучевой терапии с предполагаемыми результатами для пациентки. Особое внимание должно быть посвящено и проведению инструментального обследования с использованием методов лучевой диагностики из-за негативного влияния ионизирующего излучения на развитие эмбриона. На основе международных данных литературы в статье представлены особенности инструментальной и инвазивной диагностики беременных пациенток, у которых одномоментно была диагностирована саркома опорно-двигательного аппарата. Освещены основные подходы к лечению этой редкой группы больных, которые используются в современной онкологии.

Ключевые слова

саркома
беременность
диагностика
лечение

Дата поступления: 01.09.2025

Дата принятия в печать: 23.09.2025

Дата публикации: 14.05.2026

Литература / References

Peccatori FA, Azim HA Jr, Orecchia R, et al. Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24(6):vi160–70.
Boudy A.S, Zaccarini F. Selleret L. et al. Oncological management of pregnancy-associated cancers: analysis from the French CALG (Cancer Associ. La Grossesse) network. Acta Oncol. 2020 Jun 11:1–8. https://doi.org/10.1080/0284186X.2020.1767300
Kalampokas E, Vlahos N, Kalampokas T, Gurumurthy M., Common malignancies during pregnancy: a comprehensive review. Cancer Diagn Progn. 2021. 1 (3),103–109. https://doi.org/10.21873/cdp.10015
Maggen C, Wolters VERA, Cardonick E, Fumagalli M,Halaska MJ, Lok CAR, de Haan J, Van Tornout K, Van Calsteren K, Amant F. Pregnancy and Cancer: The INCIP Project. Curr. Oncol. Rep. 2020, 22.
Franchi A. Epidemiology and classification of bone tumours. Clin Cases Miner Bone Metab. 2012; 9 (2): 92–95.
Ульрих Е.А., Салогуб Г.Н., Калинина Е.А., Безруких В.А., Дикарева Е.Л., Комличенко Э.В., Ли О.А., Первунина Т.М. Клинический опыт лечения злокачественных новообразований на фоне беременности. Онкогинекология. 2021;2:68-80.
Zarkavelis, G., Petrakis, D., Fotopoulos, G., Mitrou, S., Pavlidis, N., 2016. Bone and soft tissue sarcomas during pregnancy: a narrative review of the literature. J. Adv. Res. 7 (4), 581–587.
Wiratnaya I.G.E. Internal hemipelvectomy is a safe procedure and provides a satisfying outcome for pelvic chondrosarcoma with coexisting pregnancy. Journal of Clinical Orthopaedics and Trauma. 2019;10: 1059e1064.
Li RSO, Maglangit SAC, Jemimah T, Cartagena-Lim , Dofitas RB. Case of a huge recurrent retroperitoneal liposarcoma diagnosed in the second trimester of pregnancy. BMJ Case Rep 2021;14:e243639. https://doi.org/10.1136/bcr-2021-243639
Bunch K, Deering SH. Primary Pulmonary Synovial Sarcoma in Pregnancy. Case Reports in Obstetrics and Gynecology. 2012; 1:326031. https://doi.org/10.1155/2012/326031
Santos TA, Américo MG, Priante AVM, Oliveira MF, Anbinder AL. Jaw osteosarcoma and pregnancy: a rare coexistence. Autops Case Rep. [Internet]. 2022;12:e2021359. https://doi.org/10.4322/acr.2021.359
Figueiro-Filho EA, Al-Sum H, Parrish J, Wunder JS, Maxwell C. Maternal and Fetal Outcomes in Pregnancies affected by Bone and Soft Tissue Tumors. Am J Perinatol Rep. 2018;8:e343–e34.
Merimsky O, Inbar M, Issakov J, Gestation-related malignant musculoskeletal tumors. Isr Med Assoc J. 2003;5(04):264–267.
Choong CL, Kurisunkal V, Stevenson J, Jeys L. Defining the management of bone and soft tissue sarcoma diagnosed during pregnancy using 38-year data collected in a single centre. Clinical Surgical Oncology.2023;2: 100023. https://doi.org/10.1016/j.cson.2023.100023
Puvanesarajah V, Spiker AM, Shannon BA, Grundy M, Levin AS, Morris CD. Evaluation and management of the pregnant patient with suspected primary musculoskeletal tumor or metastatic carcinoma to bone. Surg Oncol. 2016;25(03):212–222.
Postl LK, Gradl G, von Eisenhart-Rothe R, Toepfer A, Pohlig F, Burgkart R. Management of musculoskeletal tumours during pregnancy: a retrospective study. BMC Wom. 2015; 15: 48.
Molho RB, Kollender Y, Issakov J, Bickels J, Flusser G, Azem F, et al., The complexity of management of pregnancy-associated malignant soft tissue and bone tumours. Gynecol. Obstet. Invest. 2008.65 (2), 89–95.
Стенина М.Б., Пароконная А.А., Полушкина Е.С., Ульрих Е.А., Хохлова С.В., Шмаков Р.Г. Практические рекомендации по особенностям лекарственной терапии солидных опухолей на фоне беременности. Практические рекомендации RUSSCO, часть 1. Злокачественные опухоли. 2023; 13(3s2): стр. 709–724. https://doi.org/10.18027/2224-5057-2024-14-3s2-1.1-03
Zagouri F, Dimitrakakis C, Marinopoulos S, et al. Cancer in pregnancy: disentangling treatment modalities. ESMO Open. 2016;1:e000016. https://doi.org/10.1136/esmoopen-2015-000016
Shim, M.H., Mok, C.W., Chang, K.H., Sung, J.H., Choi, S.J., Oh, S.Y., et al., Clinical characteristics and outcome of cancer diagnosed during pregnancy. Obstet Gynecol Sci. 2016;59 (1): 1–8.
Guidelines for diagnostic imaging during pregnancy and lactation. Committee Opinion No. 723. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2017;130:e210–6.
Kanal E, Barkovich AJ, Bell C, Borgstede JP, Bradley WG Jr, Froelich JW, et al. ACR guidance document on MR safe practices: 2013. Expert Panel on MR Safety. J Magn Reson Imaging. 2013;37:501–30.
de Haan J, Vandecaveye V, Han SN, et al. Difficulties with diagnosis of malignancies in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2016;33:19-32. https://doi.org/10.1016/j.bpobgyn.2015.10.005
Chen MM, Coakley FV, Kaimal A, Laros RK Jr. Guidelines for computed tomography and magnetic resonance imaging use during pregnancy and lactation. Obstet Gynecol. 2008;112:333–40.
Ray JG, Vermeulen MJ, Bharatha A, Montanera WJ, Park AL. Association between MRI exposure during pregnancy and fetal and childhood outcomes. JAMA. 2016;316(9):952-961.
Gjelsteen AC, Ching BH, Meyermann MW, Prager DA, Murphy TF, Berkey BD, et al. CT, MRI, PET, PET/CT, and ultrasound in the evaluation of obstetric and gynecologic patients. Surg Clin North Am. 2008;88:361–90.
Grimer RJ, Carter SR, Spooner D, Sneath RS. Diagnosing musculoskeletal tumours. Sarcoma. 2001;5(2):89–94.
ACOG, 2011. Committee Opinion No. 696: nonobstetric surgery during pregnancy. Obstet. Gynecol. 2019;133(4): 285-286.
Cohen-Kerem, R., Railton, C., Oren, D., Lishner, M., Koren, G. Pregnancy outcome following non-obstetric surgical intervention. Am. J. Surg. 2005;190 (3), 467–473.
Choong C.L., Kurisunkal V., Stevenson J., Jeys L. Defining the management of bone and soft tissue sarcoma diagnosed during pregnancy using 38-year data collected in a single centre. Clinical Surgical Oncology. 2023; 2:100023 https://doi.org/10.1016/j.cson.2023.100023
Figueiro-Filho E.A., Al-Sum H., Parrish J., Wunder J.S., Maxwell C. Maternal and fetal outcomes in pregnancies affected by bone and soft tissue tumors. Am J Perinatol Rep. 2018;8:e343–e34.
Molho RB, Kollender Y, Issakov J, et al. The complexity of management of pregnancy-associated malignant soft tissue and bone tumors. Gynecol Obstet Invest. 2008;65(02):89–95.
Postl L.K., Gradl G., von Eisenhart-Rothe R., Toepfer A., Pohlig F., Burgkart R., Rechl H., Kirchhoff C. Management of musculoskeletal tumors during pregnancy: a retrospective study. BMC Women’s Health. 2015; 15:48. https://doi.org/10.1186/s12905-015-0204-3
Loibl S, Han SN, von Minckwitz G, Bontenbal M, Ring A, Giermek J, et al. Treatment of breast cancer during pregnancy: an observational study. Lancet Oncol. 2012;13(9):887–96. https://doi.org/10.1016/S1470-2045(12)70261-9
Avilès A, Nambo MJ, Huerta-Guzmàn J, Neri N, Cleto S. Speckletracking echocardiography to detect cardiac toxicity in children who received anthracyclines during pregnancy. Clin Lymphoma Myeloma Leuk. 2016;16(1):1–4.
Mir O, Berveiller P, Ropert S, Goffinet F, Goldwasser F. Use of platinum derivatives during pregnancy. Cancer. 2008; 113:3069–3074.
Thiersch JB. Therapeutic abortions with a folic acid antagonist, 4-aminopteroylglutamic acid (4-amino P.G.a) administered by the oral route. Am J Obstet Gynecol. 1952;63(6):1298-1304.
Milunsky A, Graef JW, Gaynor MF Jr. Methotrexate-induced congenital malformations. J Pediatr. 1968;72(6):790-795.
Miller D., Livingston J.A., Park Y., Posey K., Godbole S. et. Al. Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy. Cancer Medicine. 2022; 11 (18): 3471-3478. https://digitalcommons.wustl.edu/oa_4/684
Mir O., Berrada N., Domont J., Cioffi A., Boulet B., Terrier P. Doxorubicin and ifosfamide for high-grade sarcoma during pregnancy. Cancer Chemother. Pharmacol. 2012; 69 (2), 357–367.
Mazzola R, Corradini S, Eidemueller M, Figlia V, Fiorentino A, Giaj-Levra N, Nicosia L, Ricchetti F, Rigo M, Musola M, Ceccaroni M, Gori S, Magrini SM, Alongi F. Modern radiotherapy in cancer treatment during pregnancy. Crit Rev Oncol Hematol. 2019;136:13–9. https://doi.org/10.1016/j.critrevonc.2019.02.002
Kal HB, Struikmans H. Radiotherapy during pregnancy: fact and fiction. Lancet Oncol 2005;6:328–33.
Huvos A, Butler A, Bretsky S. Osteogenic sarcoma in pregnant women: prognosis, therapeutic implications and literature review. Cancer 1985;56:2326 –31.
Postl L.K., Gradl G., von Eisenhart-Rothe R., Toepfer A., Pohlig F., Burgkart R., Rechl H., Kirchhoff C. Management of musculoskeletal tumors during pregnancy: a retrospective study. BMC Women’s Health. 2015;15:48 https://doi.org/10.1186/s12905-015-0204-3

Саркомы мягких тканей и костей, ассоциированные с беременностью

Резюме

Ключевые слова

Рекомендуем статьи по данной теме: